NASDAQ: QURE - uniQure

Yield per half year: +58.33%
Dividend yield: 0.00%
Sector: Healthcare

Share chart uniQure

Extended chart Simple chart
Financial Markets by TradingView

About uniQure

uniQure NV - компания, специализирующаяся на генной терапии. Он разрабатывает лечение и платформу для пациентов, страдающих генетическими и другими серьезными заболеваниями. Его продукты и услуги ориентированы на гемофилию, болезнь Хантингтона и сердечно-сосудистые заболевания. В сотрудничестве с Bristol Myers-Squibb компания сосредоточена на разработке линейки генных методов лечения сердечно-сосудистых заболеваний.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2007-06-20
ISIN NL0010696654
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.uniqure.com
Цена ао 14.36
Change price per day: +4.2% (8.57)
Change price per week: -0.3348% (8.96)
Change price per month: -33.06% (13.34)
Change price per 3 month: -35.52% (13.85)
Change price per half year: +58.33% (5.64)
Change price per year: +86.82% (4.78)
Change price per 3 year: -39.21% (14.69)
Change price per 5 year: -78.21% (40.98)
Change price per 10 year: -52.22% (18.69)
Change price per year to date: -45.75% (16.46)
All parameters

Underestimation

Title Value Grade
P/S 30.89 1
P/BV -124.07 0
P/E 2.19 10
EV/EBITDA -4.04 0
Total: 4.63

Efficiency

Title Value Grade
ROA, % -34.51 0
ROE, % -238.46 0
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.3585 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % -27.68 0
Yield Ebitda, % 61.95 8
Yield EPS, % 75.24 8
Total: 5.8
More

Institutions Volume Share, %
Nantahala Capital Management, LLC 5916054 12.37
Vestal Point Capital, LP 3925000 8.2
State Street Corporation 3478872 7.27
Blackrock Inc. 1836696 3.84
Morgan Stanley 1759818 3.68
683 Capital Management LLC 1693000 3.54
Orbimed Advisors LLC. 1347900 2.82
Pictet Asset Management Holding SA 1324246 2.77
International Biotechnology Trust PLC 1241500 2.6
Schroder Investment Management Group 1241500 2.6

ETFShare, %Profitability for 1 year, %Dividends, %
Principal Healthcare Innovators ETF 0.02271 618.5 0.8416
Future Tech ETF 0.02271 426.34 0.8416
0.02522.420.84



Head Job title Payment Year of birth
Mr. Matthew Craig Kapusta CEO & Executive Director 1.16M 1972 (53 years)
Mr. Christian Klemt CFO, Principal Financial Officer & GM of Amsterdam Site 566.36k 1973 (52 years)
Prof. Hugo Katus Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany N/A
Ms. Maria E. Cantor Chief Corporate Affairs Officer 491.12k 1968 (57 years)
Dr. Tamara Tugal Ph.D., MBA Business Development Director N/A
Dr. Jeannette Potts J.D., Ph.D. Chief Legal & Compliance Officer and Corporate Secretary N/A 1962 (63 years)
Mr. Richard Porter Ph.D. Chief Business & Scientific Officer N/A 1968 (57 years)
Dr. Amin Abujoub Ph.D. Chief Technical Operations N/A
Dr. Walid Abi-Saab M.D. Chief Medical Officer 1965 (60 years)
Eileen Sawyer Vice President of Global Medical Affairs

Address: Netherlands, Amsterdam BP, Paasheuvelweg 25a - open in Google maps, open in Yandex maps
Website: http://www.uniqure.com